CR can definately happen, they even raised funding during the GFC at 16 cents a share. Its just a matter about price, they dont give a ...... how much your shares get diluted, only the institutions have been getting meaningful access to the CR's lately.
Partner funding in my opinion is pie in the sky, i'm not trying to attack you for thinking that but I just have strong opinions that Starpharma needs to stand on its own two feet to get their funding.
It will be a huge step forward if Starpharma ever manages to get meaningful funding from another company, only time will tell if even Astrazenica is going to provide funding in excess of development costs to Starpharma.
We are a perpetual money pit until we get a good product to market.
My opinions are on the conservative side as 10 years is a long time to gauge what assistance others are extending to SPL. Show me the money and then i'll change my opinion.
SPL Price at posting:
69.5¢ Sentiment: Hold Disclosure: Held
